ClinicalTrials.Veeva

Menu

In-vitro Effect of Mangosteen Pericarp Extract on Cell Lines (invitro)

M

Meenakshi Ammal Dental College and Hospital

Status

Completed

Conditions

Apoptosis

Treatments

Other: mangosteen extract

Study type

Interventional

Funder types

Other

Identifiers

NCT03728192
MAHER-MU-004-IEC/2016

Details and patient eligibility

About

The present study is an effort to investigate the hypothesis that in-vitro vitality and antiapoptotic effect of alcoholic crude extract of mangosteen on Oral cancer( H357) cell lines and Cevical cancer (HeLa) cell lines.

Full description

The oral and cervical cells were investigated by MTT (3-4,5- dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide) assay, DNA fragmentation detection by TUNEL (Terminal deoxynucleotidyl transferase-mediated d-UTP Nick End Labeling) assay and Apototic assay using Annexin V/FITC Kit.

Enrollment

2 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with oral squamous cell carcinoma
  • Patients with cervical carcinoma

Exclusion criteria

• Patients with leukaemia

Trial design

Primary purpose

Prevention

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

2 participants in 2 patient groups

Mangosteen treated group
Experimental group
Description:
HeLa and H357 cell lines were procured and were further subdivided into 2 subdivisions and were assigned interventions: Mangosteen group- cells treated with mangosteen extract and Camptothecin group - cells treated with standard anticancer drug camptothecin(25 micro mole)
Treatment:
Other: mangosteen extract
Untreated group
No Intervention group
Description:
H357 and HeLa cell line without any drug intervention.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems